CClinicalTrials.gg
CompletedNCT07328282Updated Sep 4, 2026

Comparative Effects Between ELDOA and Spinal Mobilization With Limb Movement in Lumbar Radiculopathy

An interventional study of ELDOA and Spinal Mobilization with Limb Movement - SMWLM in Lumbar Radiculopathy, sponsored by Foundation University Islamabad. Completed at 1 site in Pakistan. Open to participants aged 30 Years to 50 Years. Per ClinicalTrials.gov, last updated 2026-09-04.

Sponsored by Foundation University Islamabad · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
44
Allocation
Randomized
Ages
30 Years to 50 Years
Sex
All
01

Study summary

This study examines the comparative effects of ELDOA and Spinal Mobilization with Leg Movement (SMWLM) on lumbar radiculopathy

Read the detailed description

Participants were randomly assigned into two groups:

Group A, which performed structured ELDOA exercises targeting spinal decompression and postural alignment Group B, which received SMWLM interventions focusing on spinal mobilization combined with controlled leg movements.

Pain, functional disability, and lumbar range of motion were measured using Visual Analog Scale, Oswestry Disability Index, and bubble inclinometer

02

Conditions studied

  • Lumbar Radiculopathy

Keywords

  • Lumbar Radiculopathy
  • lumbar pain
03

In context

Radiculopathy

488 studies on the registry are indexed under Radiculopathy; 141 are open to participants now.

This study's enrollment of 44 is below the median of 60 across 376 interventional studies indexed under Radiculopathy.

Browse Radiculopathy studies →

Lead sponsor

Foundation University Islamabad is the lead sponsor of 238 studies on the registry; 128 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
30 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria:

  • Age 30 -50 years
  • both male and female
  • Unilateral lumbar radiculopathy of L4/L5
  • Posteriolateral mild disc herniation on MRI
  • SLR test positive (30 to 70) degree
  • crosed SLR test positive
  • Slump test positive
  • pain and symptoms disturbution in dermatomal pattern of L4 and L5 Exclusion Criteria
  • MRI findings indicating i.Spinal instability ii. Significant neuroforaminal stenosis iii. Structural abnormalities requiring surgical intervention (e.g., large disc herniation )
  • Clinical findings indicating:

    i. Absence of severe neurological and severe motor weakness (Manual Muscle Testing grades 0, 1, or 2) ii. Signs of cauda equina lesion (e.g., saddle anesthesia, bowel/bladder dysfunction)

  • Diagnosed spinal conditions i. Lumbar spondylolisthesis ii. Lumbar spine fracture iii. Spinal stenosis iv. Spinal tumor v. Ankylosing spondylitis
  • History of previous spinal surgery Pregnancy Presence of severe neurological and severe motor weakness
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
44 participants (actual)

Study arms

  • Experimental
    ELDOA

    Group A will recieve standard treatment of ELDOA Strengthening will be divided into following phases 1. Warm up phase: 2. Strengthening phase: 3. Cool down phase:

    Procedure: ELDOA

  • Experimental
    Spinal mobilization with limb movement (SMWLM)

    Group B will receive Standard treatment of spinal mobilzation and limb movement Strengthening will be divided into following phases 1. Warm up phase: 2. Strengthening phase: 3. Cool down phase:

    Procedure: Spinal Mobilization with Limb Movement - SMWLM

Interventions

  • ProcedureELDOA

    Participants will receive a four-week physiotherapy program with three sessions per week. Each session will heat application followed by supervised stretching and strengthening exercises. Participants in Group A will receive ELDOA in addition to standard physiotherapy. Each position will be sustained for at least one minute, with gradual progression to the full posture as flexibility and control improve.

  • ProcedureSpinal Mobilization with Limb Movement - SMWLM

    Participants will receive a four-week physiotherapy program with three sessions per week. Each session will heat application followed by supervised stretching and strengthening exercises. Participants in Group B will receive spinal mobilization combined with limb movement along with standard physiotherapy. The technique will be repeated three times.

06

What researchers measure

Primary outcomes

  1. Functional Disability

    Measured by Oswestry Disability Index, a 10-item questionnaire with six response options per item.

    Time frame: baseline, 2nd and 4th week

  2. Pain Intensity

    Pain severity will be measured using the Visual Analog Scale ranging from 0 (no pain) to 10 (worst imaginable pain).

    Time frame: baseline, 2nd week, 4th week

  3. Lumbar Range of Motion

    Lumbar spine range of motion will be assessed using a bubble inclinometer.

    Time frame: baseline, 2nd and 4th week

07

Study locations

1 site
  • Foundation University College of Physical Therapy
    Islamabad, Punjab Province 46000, Pakistan
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 4, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07328282
Lead sponsor
Foundation University Islamabad
Responsible party
Sponsor
First posted
Jan 9, 2026
Start date
Nov 19, 2025
Primary completion
Apr 26, 2026
Completion
May 25, 2026
Last update
Sep 4, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion